T1	intervention 0 10	Ultrasound
T2	control 34 60	magnetic resonance imaging
T3	eligibility 495 531	Patients with invasive breast cancer
T5	total-participants 601 604	182
T6	control-participants 663 666	155
T7	intervention-participants 675 678	123
T8	outcome 730 774	residual tumour size with <10-mm discordance
T9	cv-bin-percent 778 781	54%
T10	outcome 795 813	overestimated size
T11	cv-bin-percent 817 820	28%
T12	outcome 825 844	underestimated size
T13	cv-bin-percent 848 851	18%
T14	iv-bin-percent 883 886	63%
T15	iv-bin-percent 888 891	20%
T16	iv-bin-percent 896 900	17%,
T17	outcome 919 944	negative predictive value
T18	cv-bin-percent 1011 1014	26%
T19	iv-bin-percent 1019 1022	33%
T20	cv-cont-median 1124 1127	63%
T21	iv-cont-median 1150 1153	49%
T22	outcome 1042 1082	median deviation in clinical tumour size
